Jane Street Group LLC Has $259,000 Stock Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Jane Street Group LLC decreased its position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 90.0% during the 3rd quarter, Holdings Channel reports. The firm owned 5,839 shares of the company’s stock after selling 52,269 shares during the quarter. Jane Street Group LLC’s holdings in SPDR S&P Pharmaceuticals ETF were worth $259,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in XPH. Stifel Financial Corp bought a new stake in SPDR S&P Pharmaceuticals ETF during the 3rd quarter worth about $337,000. BNP Paribas Financial Markets grew its holdings in SPDR S&P Pharmaceuticals ETF by 208.6% during the 3rd quarter. BNP Paribas Financial Markets now owns 149,419 shares of the company’s stock worth $6,628,000 after acquiring an additional 101,000 shares during the last quarter. First Citizens Bank & Trust Co. grew its holdings in SPDR S&P Pharmaceuticals ETF by 9.5% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 72,053 shares of the company’s stock worth $3,196,000 after acquiring an additional 6,227 shares during the last quarter. AlphaMark Advisors LLC grew its holdings in SPDR S&P Pharmaceuticals ETF by 5.9% during the 3rd quarter. AlphaMark Advisors LLC now owns 6,225 shares of the company’s stock worth $276,000 after acquiring an additional 348 shares during the last quarter. Finally, Rockport Wealth LLC bought a new stake in SPDR S&P Pharmaceuticals ETF during the 2nd quarter worth about $1,813,000.

SPDR S&P Pharmaceuticals ETF Trading Down 0.2 %

Shares of NYSEARCA XPH opened at $42.72 on Friday. The firm has a market capitalization of $207.19 million, a PE ratio of 14.39 and a beta of 0.87. SPDR S&P Pharmaceuticals ETF has a 1 year low of $38.88 and a 1 year high of $48.76. The firm’s 50-day moving average is $44.96 and its 200-day moving average is $43.93.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.